S-(Benzo[d]thiazol-2-yl)-N,N-dicyclohexylthiohydroxylamine, 95.0%, 10g

Decahydro-1,4-naphthalenedicarboxylic Acid (mixture of isomers)>96.0%(GC)(T)1g

(R)-4-PHENYL-2-(5-(TRIFLUOROMETHYL)PYRIDIN-2-YL)-4,5-DIHYDROOXAZOLE, 95%, 100mg

3-Fluoro-5-(trifluoromethyl)benzylamine, 97.0%, 10g

(R)-1-BOC-PYRROLIDINE-3-CARBOXYLIC ACID HYDRAZIDE, 95.0%, 250mg

5-Bromo-3-methyl-2-morpholinocarbonylpyridine, 95+%, 1g

4-(3-Tosyl-2-(tosylmethyl)propanoyl)benzoic acid, 97.0%, 5g

GC capillary column ROTI®Cap-1701, 15 m, 0.53 mm, 1.00 µm, 1 Piece(s)

2-Amino-3-(4-iodophenyl)propanoic acid, 95.0%, 100g

6-Chloro-4-methoxypyridazin-3-amine, 95.0%, 250mg

4-Methyl-3-nitrobenzenesulfonamide, 95.0%, 5g

2-(3-Fluoro-4-methoxyphenyl)acetamide, 95%, 5g

4-phenyl-4,5-dihydro-1H-1,2,4-triazol-5-one, 97%, 1g